Related Experiment Video

Updated: Jul 11, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries

Takuya Shimizu1, Tatsu Nakazawa, Aesim Cho

  • 1Department of Pathology, University of Washington, 815 Mercer St, Seattle, WA 98109, USA.

Circulation Research
|September 18, 2007
PubMed

Insights

Sphingosine 1-phosphate receptor 2 (S1P2) deficiency promotes neointimal lesion formation and smooth muscle cell (SMC) growth in arteries. S1P2 activation normally suppresses SMC proliferation, regulating neointimal development.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Signaling

Background:

  • Neointimal hyperplasia is a key process in vascular diseases.
  • Sphingosine 1-phosphate (S1P) signaling pathways are implicated in vascular remodeling.
  • The specific role of sphingosine 1-phosphate receptor 2 (S1P2) in neointimal formation requires further elucidation.

Purpose of the Study:

  • To investigate the role of S1P2 in neointimal lesion formation and smooth muscle cell (SMC) behavior.
  • To determine the impact of S1P2 deficiency on SMC proliferation and migration in response to vascular injury.

Main Methods:

  • Neointimal lesion formation was induced in S1P2-null and wild-type mice via carotid artery ligation.
  • Smooth muscle cell proliferation and migration assays were performed.
  • Rho activation was assessed in response to S1P stimulation.

Main Results:

  • S1P2-null mice exhibited significantly larger neointimal lesions compared to wild-type controls.
  • SMC replication and migration were markedly increased in S1P2-null arteries.
  • S1P-induced Rho activation was impaired in S1P2-null SMCs, and Rho inhibition enhanced S1P-mediated migration.

Conclusions:

  • S1P2 activation normally suppresses SMC growth and proliferation in arteries.
  • S1P signaling through S1P2 is a critical regulator of neointimal development following vascular injury.
  • Targeting S1P2 may offer a therapeutic strategy for preventing vascular hyperplasia.

More Related Videos

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium05:53

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium

Published on: March 4, 2016

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...